(Q34151750)

31 July 2017

Treatment of multiple sclerosis with the pregnancy hormone estriol (English)

1 reference

31 July 2017

0 references

Nancy L Sicotte

1

1 reference

31 July 2017

Stephanie M Liva

2

1 reference

31 July 2017

Rochelle Klutch

3

1 reference

31 July 2017

Paul Pfeiffer

4

1 reference

31 July 2017

Seth Bouvier

5

1 reference

31 July 2017

Sylvia Odesa

6

1 reference

31 July 2017

T C Jackson Wu

7

1 reference

31 July 2017

Rhonda R Voskuhl

8

1 reference

31 July 2017

1 October 2002

1 reference

31 July 2017

1 reference

31 July 2017

52

1 reference

31 July 2017

421-428

1 reference

31 July 2017

4

1 reference

Immunological aspects of demyelinating diseases

31 July 2017

1 reference

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

21 January 2018

1 reference

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

21 January 2018

1 reference

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

21 January 2018

1 reference

The role of pregnancy in the course and aetiology of rheumatoid arthritis

21 January 2018

1 reference

Remission of Rheumatoid Arthritis During Pregnancy and Maternal‐Fetal Class II Alloantigen Disparity

21 January 2018

1 reference

Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis

21 January 2018

1 reference

Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains

21 January 2018

1 reference

Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis

21 January 2018

1 reference

Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect

21 January 2018

1 reference

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

21 January 2018

1 reference

Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production

21 January 2018

1 reference

Surface-based labeling of cortical anatomy using a deformable atlas.

21 January 2018

1 reference

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

21 January 2018

1 reference

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis

21 January 2018

1 reference

TCR peptide therapy in human autoimmune diseases

21 January 2018

1 reference

17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Female sex steroids: effects upon microglial cell activation

21 January 2018

1 reference

High-dose estradiol improves cognition for women with AD: results of a randomized study

21 January 2018

1 reference

Cognitive performance in surgically menopausal women on estrogen.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10301

1 reference

31 July 2017

1 reference